Alamar Biosciences (ALMR): Soros Fund Management exited its position 60K shares
Soros Fund Management exited its position in Alamar Biosciences, per its Q3 2026 13F.
- 60K
- Prior-quarter shares · no longer reported
- Holdings as of
- Sep 30, 2026
- Filed
- Nov 13, 2026
What stands out in this filing
- The manager reported no shares in Q3 2026, after 60,000 in its Q2 2026 filing.
- No other tracked manager reported the same kind of change for Q3 2026.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 17, 2026Federal contract · $57K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $57K obligated to date
- Sep 18, 2026Federal contract · $100K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $100K obligated to date
- Sep 21, 2026Federal contract · $40K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $40K obligated to date
- Oct 15, 2026Insider · 1 personInsiders: 8 sales (~$4.8M)
- Oct 16, 2026Insider · 1 personInsiders: 4 sales (~$4K)
- Oct 19, 2026Insider · 1 personInsiders: 4 sales (~$2.0M)
- Oct 20, 2026Insider · 1 personInsiders: 12 sales (~$4.0M)
- Oct 21, 2026Insider · 1 personInsiders: 12 sales (~$6.3M)
- Oct 22, 2026Insider · 1 personInsiders: 12 sales (~$3.9M)
- Oct 23, 2026Insider · 1 personInsiders: 12 sales (~$4.5M)
- Oct 26, 2026Insider · 1 personInsiders: 8 sales (~$4.0M)
- Oct 27, 2026Insider · 1 personInsiders: 5 sales (~$679K)
- Oct 30, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“After more than five years of exemplary service, on October 30, 2026, Timothy “Tod” White informed the Company that he will retire from his current position as President of the Company, effective as of December 31, 2026.”
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Alamar Biosciences
For Alamar Biosciences, OQRO holds 132 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALMR page.
How this filing works
Explore the data
Common questions
What does this filing report about Alamar Biosciences (ALMR) stock?
Soros Fund Management exited its position in Alamar Biosciences, per its Q3 2026 13F. Held the prior quarter, no longer listed per its Q3 2026 13F.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2026. Filed: Nov 13, 2026.
What stands out in this filing?
The manager reported no shares in Q3 2026, after 60,000 in its Q2 2026 filing. No other tracked manager reported the same kind of change for Q3 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Alamar Biosciences recently?
For Alamar Biosciences, OQRO holds 132 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days. They are listed on the ALMR page.
Does this mean ALMR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Alamar Biosciences
- SEC Form 4Nov 14, 2026
- SEC Form 4Nov 14, 2026
- SEC Form 4Nov 14, 2026
- SEC Form 4Nov 14, 2026
- SEC Form 4Nov 14, 2026
- SEC Form 4Nov 14, 2026
Everything OQRO holds on this company is on its ALMR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data